Hotline Service for Drug-abusing Youth and Young Adults

November 2, 2020 updated by: Dr. LI William Ho Cheung, The University of Hong Kong

MedPAC Hotline: A Medical Peer Addiction Counselling Hotline Service for Drug-abusing Youth and Young Adults

Aim: Providing peer counselling service delivered by student counsellors with a medical background via a hotline to drug-abusing youth and young adult aged 35 or below.

Objectives:

i. To raise anti-drug awareness of young people in general and identify high-risk/hidden drug-abusing youth and young adult aged 35 or below in Hong Kong; and ii. To train university students with a medical background as peer counsellors; and iii. To provide drug abuse hotline service by students with a medical background as peer counsellors to drug-abusing youth and young adult aged 35 or below, and other people who call for help, including drug abusers' family members, friends, and professionals; and iv. To improve the drug-abusing youth and young adult' knowledge about the hazard of drug abuse, negative attitude, and perception towards the drug abuse through the telephone peer counselling service provided by students with medical background; and v. To increase the intention to quit and the help-seeking behavior among the drug-abusing youth and young adult; vi. To increase reduction rate and abstinence rate from drug abuse, and decrease the relapse rate among drug-abusing youth and young adult through the telephone peer counseling service.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The MedPAC Hotline Service will be promoted to high-risk and drug-abusing youth and young adults through a variety of platforms, namely schools and youth service organizations, industries, community, mass media and internet, social media, posters and snowball approach.

The hotline service will operate from 5 p.m. to 9 p.m. on weekday and from 2 p.m. to 8 p.m. on weekend. A peer counsellor or a research assistant will answer the telephone inquiries from 9:30 a.m. to 5 p.m. on weekdays.

About 50 university students will be trained as peer counsellors through a structured training programme. The students will be invited to complete the pre, post and 6-month self-administered questionnaire before, immediately and 6-month after the training programme to examine their changes of knowledge of and attitudes towards addiction counselling. A satisfaction survey will also be conducted to measure their perception on the quality of training programme.

Peer counsellors will use telephone-based, Peer-led Brief Motivational Interviewing (BMI) counselling to motivate and encourage drug-abusing or high-risk youth and young adults to rehabilitate from drug abuse, assist them to manage the withdrawal symptoms, and help identify barriers and facilitators to rehabilitate from drug abuse in the telephone counselling. The peer counsellors will give referral advices if the youth and young adult needs appropriated treatment and rehabilitation services.

The drug-abusing youth and young adults will be counselled and invited to complete the follow-up questionnaires over the telephone after joining the MedPAC Hotline Service programme for 1 week, 1 month, 3 months, 6 months, 9 months and 1 year. Self-reported quitters at 6-month and 1-year follow-ups were invited to have urine test to validate the drug abuse abstinence status.

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Pokfulam
      • Hong Kong, Pokfulam, Hong Kong
        • Recruiting
        • The University of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 35 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The inclusion criteria of target service group for this quitline programme is that current drug abusers in Hong Kong who should (1) be aged 35 or below, (2) be able to communicate in Cantonese, and (3) have a history of drug abuse within the past 12 months (including all types of drugs such as narcotics analgesics, hallucinogens, depressants, stimulants, tranquillizers and other recreational drugs).
  • The inclusion criteria of peer counsellors providing counselling service in this quitline programme are those who should (1) be aged 18 - 35, (2) be able to communicate in Cantonese, (3) have a medical background, (4) complete the training courses and pass the evaluation of peer counsellor qualification.

Exclusion Criteria:

  • Those who are psychologically or physically unable to communicate will be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Peer-led counselling
  1. About 50 university students trained as peer telephone counsellors through a structured training programme.
  2. About 200 Drug-abusing youth and young adults received telephone-based, Peer-led Brief Motivational Interviewing (BMI)

About 50 university students will be trained as peer counsellors through a structured training programme. A pre and post and 6-month self-administered questionnaire will be conducted before, immediately and 6-month after the training programme to examine their changes of knowledge and attitudes. A satisfaction survey will also be conducted to measure participants' perception of the quality of the training programme.

Drug-abusing youth and young adults will receive telephone-based, Peer-led Brief Motivational Interviewing (BMI) counselling to rehabilitate from drug abuse. The peer counsellors will give referral advice if the youth and young adult needs appropriate treatment and rehabilitation services.

The drug abusers will be counselled and invited to complete the follow-up questionnaires at 1 week, 1 month, 3 months, 6 months, 9 months and 1 year. Self-reported quitters at 6-month and 1-year follow-ups will be invited to have a urine test to validate the drug abuse abstinence.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in drug consumption at 12-month follow-up
Time Frame: Baseline and 12 months
Drug abuser's drug consumption is measured at 12-month follow-up. A questionnaire asking the frequency of drug use in the past 30 days will be used for assessing the self-reported change in drug consumption.
Baseline and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30 days self-reported drug abstinence at 6-month and 12-month follow-up
Time Frame: Baseline, 6 months and 12 months
Self-reported drug abstinence (do not use drug for at least 30 days during the time of follow-up) at 6-month and 12-month. A questionnaire asking the drug use status, quitting experience will be used for assessing the self-reported drug abstinence.
Baseline, 6 months and 12 months
Change in drug consumption at 6-month follow-up
Time Frame: Baseline and 6 months
Drug abuser's drug consumption is measured at 6-month follow-up. A questionnaire asking the frequency of drug use in the past 30 days will br used for assessing the self-reported change in drug consumption.
Baseline and 6 months
Change in relapse risk among the quitters
Time Frame: Baseline and 12 months
Drug quitter's relapse risk is measured at 12-month follow-up. A questionnaire using Stimulant Relapse Risk Scale (SRRS) with the questions of the intention to use drugs, compulsivity for drugs and impetus and confidence to avoid drugs etc. will be used for assessing the relapse risk at 12-month follow-up. The higher the scores, the higher the relapse risk.
Baseline and 12 months
Change of the contemplation stage
Time Frame: Baseline, 6 months and 12 months
Drug abuser's change of the contemplation stage at 6-month and 12-month follow-up. A questionnaire asking the intention to quit drug abuse and experience of drug abstinence to match the stage in contemplation ladder will be used for assessing the contemplation stage at 6-month and 12-month.
Baseline, 6 months and 12 months
Changes of the perceived treatment needs and motivation towards solving the problem of drug abuse
Time Frame: Baseline, 6 months and 12 months
Drug abuser's change of perceived treatment needs and motivation towards solving the problem among drug abusers at 6-month and 12-month. A questionnaire using the Treatment Needs/Motivation Scales (TCU MOTForm) will be used for assessing the level of the intention and motivation to receive treatment of solving the drug abuse problem. The higher the scores, the higher the perceived treatment needs and motivation.
Baseline, 6 months and 12 months
Change of self-efficacy of drug abusers to avoid drug use
Time Frame: Baseline, 6 months and 12 months
Drug abuser's change of self-efficacy to avoid drug use at 6-month and 12-month follow-up. The Adolescent Relapse Coping Questionnaire (ARCQ) will be used for evaluating the self-efficacy to avoid drug use. It comprises 6 questions for a given condition about drug temptation. The higher the score, the higher the self-efficacy of drug abusers to avoid drug use.
Baseline, 6 months and 12 months
Drug abuser's improvement of knowledge and attitude on drug abuse hazards
Time Frame: Baseline, 6 months and 12 months
Drug abuser's improvement of knowledge and attitude on drug abuse hazards at 6-month and 12-month follow-up. A questionnaire asking about the knowledge and attitude on drug abuse with a scale called "knowledge and attitude on drug abuse for drug abuser" will be used for assessing the change of knowledge and attitude on drug abuse. The higher the scores, the better the knowledge and attitude.
Baseline, 6 months and 12 months
Peer counsellor's improvement of knowledge and attitude on drug abuse hazards
Time Frame: Baseline, immediately after the training programme and 6 months
Peer counsellor's improvement of knowledge and attitude on drug abuse hazards immediately after the training programme and after 6 months will be measured by a scale called "knowledge and attitude on drug abuse for peer counsellor" in a self-reporting structured questionnaire. The higher the scores, the better the knowledge and attitude.
Baseline, immediately after the training programme and 6 months
Satisfaction of peer counsellors to the drug abuse training programme
Time Frame: Immediately after the training programme
Satisfaction of peer counsellors to the drug abuse training programme will be collected. A questionnaire asking about the comments of content, practicability, speakers from the peer counsellors with the satisfaction scale will be used for evaluating the satisfaction immediately after the training programme. The higher the scores, the greater the satisfaction of the training programme.
Immediately after the training programme

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 26, 2020

Primary Completion (Anticipated)

August 1, 2023

Study Completion (Anticipated)

August 1, 2023

Study Registration Dates

First Submitted

June 15, 2020

First Submitted That Met QC Criteria

July 2, 2020

First Posted (Actual)

July 8, 2020

Study Record Updates

Last Update Posted (Actual)

November 4, 2020

Last Update Submitted That Met QC Criteria

November 2, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • MedPAC Hotline

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The relevant anonymized patient-level data, full dataset, technical appendix, and statistical code are available on reasonable request. The approval from the Principal Investigator for the purpose of data use is required.

IPD Sharing Time Frame

After the project is completed and the results of the project have been published.

IPD Sharing Access Criteria

Request could be sent to Principal Investigator (william3@hku.hk)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Drug Abuse

Clinical Trials on peer-led counselling

Subscribe